Similarly, IL-6 also induces glycolytic enzyme expression in cancer cells via signal transducers and activators of transcription 3 (STAT3)/c-Myc signaling [28], and correlated with tumorigenesis, which together suggests that inflammation can induce metabolic reprogramming and promote cancer progression (Figure 1). This evidence concerns the gene MYC and cancer.